- Patent Title: Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia
-
Application No.: US16741542Application Date: 2020-01-13
-
Publication No.: US11713355B2Publication Date: 2023-08-01
- Inventor: Parul Doshi
- Applicant: Janssen Biotech, Inc.
- Applicant Address: US PA Horsham
- Assignee: Janssen Biotech, Inc.
- Current Assignee: Janssen Biotech, Inc.
- Current Assignee Address: US PA Horsham
- Agency: Hamilton, Brook, Smith & Reynolds, P.C.
- Main IPC: A61K39/00
- IPC: A61K39/00 ; C07K16/28 ; A61K31/475
Abstract:
The present invention relates to combination therapies with anti-CD38 antibodies.
Public/Granted literature
- US20200223936A1 Anti-CD38 Antibodies for Treatment of Acute Lymphoblastic Leukemia Public/Granted day:2020-07-16
Information query
